Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
14.06
-0.31 (-2.16%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $525.65 million as of July 24, 2026. Its market cap has increased by 269.41% in one year.
Market Cap
525.65M
Enterprise Value
286.28M
1-Year Change
269.41%
Ranking
Category
Stock Price
$14.06
ChartMarket Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $525.65M, an increase of 30.73%. That is a compound annual growth rate of 12.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 525.65M | 25.90% |
| Dec 31, 2025 | 417.53M | 10.56% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altimmune | 540.64M |
| Relmada Therapeutics | 540.18M |
| 4D Molecular Therapeutics | 537.92M |
| Prime Medicine | 536.43M |
| Verastem | 532.07M |
| Silence Therapeutics | 524.30M |
| Arvinas | 518.75M |
| Rezolute | 516.07M |